leucine has been researched along with Fabry Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, H; Kitagawa, W; Komatsuda, A; Miura, N; Nishikawa, K; Suzuki, K; Suzuki, S; Watanabe, D | 1 |
| Fervenza, FC; Lager, D; Lai, LW; Leung, N; Lien, YH; Rosenthal, D; Shang, S | 1 |
1 review(s) available for leucine and Fabry Disease
| Article | Year |
|---|---|
Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R).
Topics: Adult; alpha-Galactosidase; Arginine; Biopsy; Disease Progression; DNA Mutational Analysis; Drug Administration Schedule; Enzyme Replacement Therapy; Fabry Disease; Glomerular Filtration Rate; Humans; Isoenzymes; Kidney; Leucine; Male; Mutation; Recombinant Proteins; Renal Insufficiency; Time Factors; Treatment Outcome | 2011 |
1 other study(ies) available for leucine and Fabry Disease
| Article | Year |
|---|---|
A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease.
Topics: Aged; alpha-Galactosidase; Amino Acid Substitution; Fabry Disease; Genetic Variation; Humans; Leucine; Male; Methionine; Mutation, Missense | 2004 |